Singular Genomics Systems Net Tangible Assets

Singular Genomics Systems (OMIC) currently reports a net tangible assets of $120M as of September 2024. That compares with $200M in the prior-year period — down 38.1% year over year. Use the charts on this page to explore Singular Genomics Systems's net tangible assets history and peer comparisons.

Singular Genomics Systems's net tangible assets decreased from $200M to $120M — a 38.1% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Singular Genomics Systems reported $120M in net tangible assets as of September 2024. That compares with $200M in the prior-year period — down 38.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Singular Genomics Systems, and consider following OMIC for alerts when major investors trade the stock.

Singular Genomics Systems is classified in the Healthcare sector. On net tangible assets, it currently shows $120M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OMIC with unrelated industries.